Description du projet
Des applications pilotées par l’intelligence artificielle pour un cœur en bonne santé
Au cours des 25 dernières années, le nombre absolu de cas de maladie cardiovasculaire (MCV) a augmenté en Europe. La MCV cause actuellement 3,9 millions de décès en Europe chaque année, et représente 45 % de la totalité des décès. Dans la mesure où la maladie coronarienne se développe lentement, généralement sur plusieurs décennies, il est important d’améliorer les capacités de détection des risques individuels de progression de la maladie. Le projet TIMELY, financé par l’UE, compte mettre au point une plateforme proposant des applications et des tableaux de bord alimentés par l’intelligence artificielle, ainsi que des outils d’aide à la prise de décision, visant à aider les patients et les cliniciens à personnaliser les soins de santé sur la base de l’évaluation du risque. Le projet s’appuie sur une plateforme fonctionnelle et interopérable, et simplifiera le partage de données tout en permettant de surveiller et d’évaluer les risques de manière continue.
Objectif
Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends on multiple (often modifiable) risk factors and their interactions. Self-management and patient activation are of rising importance as current restrictions in healthcare budgets impose great difficulties to enable the provision of qualitative secondary prevention to all cardiac patients in an era facing a huge cardiovascular disease epidemic.
The main hypothesis in the patient-centered TIMELY pathway, is that a modular, collaborative eHealth platform, supported by Artificial Intelligence (AI) for the continuous and in-time prediction of cardiac risks and complications and the induction of targeted behavioural change interventions, can be effective and cost-efficient for the secondary prevention of CAD by limiting the physiological and psychological effects of the disease and improving risk factor and symptom management. Improvements in patients’ self-care and empowerment and clinicians’ efficiency are also expected.
Along the continuum of the disease, prediction of the individual risk for disease progression, including physical impairment and severe events, is mandatory for timely intervention. TIMELY is a platform that provides AI-powered apps and dashboards and decision support tools assisting patients and clinicians to personalize healthcare based on risk evaluation, outcome prediction and tailored interventions. The platform will be developed based on a functional platform for Interoperability with electronic health records and security mechanisms, to ensure information completeness and continuity and to simplify data sharing. AI in TIMELY, built with big retrospective datasets of >23.000 CAD patients, will constantly monitor and evaluate risks and will indicate any deviation from defined therapy goals or unfavorable changes as well as propose proper interventions.
Champ scientifique
Not validated
Not validated
Mots‑clés
Programme(s)
Régime de financement
RIA - Research and Innovation actionCoordinateur
1012WX Amsterdam
Pays-Bas